Canadian Cannabis EBITDA margin
Was ist das EBITDA margin von Canadian Cannabis?
EBITDA margin von Canadian Cannabis Corp. ist -3,386.17%
Was ist die Definition von EBITDA margin?
EBITDA margin is a profitability ratio that measures how much EBITDA the company generates as a percentage of revenue.
ttm (trailing twelve months)
EBITDA margin measures how much of EBITDA is generated as a percentage of sales. It measures the company’s operating profit as a percentage of its revenue and is calculated as EBITDA (earnings before interest, taxes, depreciation, and amortization) divided by total revenue.
EBITDA margin also helps with judging the effectiveness of cost-cutting processes at the company. The higher the company’s EBITDA margin, the lower operating expenses are in respect to revenue. As a result, a higher EBITDA margin is considered more favorable. Smaller companies can have higher EBITDA margins since they are able to operate more efficiently and maximize their profitability.
EBITDA excludes interest on debt, taxes, and capital expenditures, the margin does not provide a perfectly clear estimate of the business’s cash flow generation. Furthermore, EBITDA margin is not recognized as a GAAP (generally accepted accounting principles) metric.
EBITDA margin von Unternehmen in Health Care Sektor auf OTC im Vergleich zu Canadian Cannabis
Was macht Canadian Cannabis?
Canadian Cannabis Corp. focuses on the manufacture and marketing of medical marijuana products in Canada and internationally. The company intends to offer 15 different strains of dried marijuana, as well as the constituents to produce edible and elixir products for medicinal use. The company was founded in 2014 and is based in Brampton, Canada.
Unternehmen mit ebitda margin ähnlich Canadian Cannabis
- 4Dx hat EBITDA margin von -3,446.98%
- Amesite hat EBITDA margin von -3,444.77%
- Truscott Mining hat EBITDA margin von -3,437.08%
- Sequana Medical NV hat EBITDA margin von -3,402.79%
- Forward Water Technologies hat EBITDA margin von -3,400.14%
- Bee Vectoring Technologies International hat EBITDA margin von -3,391.79%
- Canadian Cannabis hat EBITDA margin von -3,386.17%
- Ngm Biopharmaceuticals Inc hat EBITDA margin von -3,378.81%
- Conico Ltd hat EBITDA margin von -3,348.47%
- Alta Zinc hat EBITDA margin von -3,337.52%
- BioCorRx hat EBITDA margin von -3,332.23%
- Aura hat EBITDA margin von -3,318.84%
- Aura hat EBITDA margin von -3,318.84%